Outcome map · Supplement

Cognition / mood: what the evidence supports

2 graded interventions for cognition / mood, ranked by strength of evidence.

Overall grade
Grade D
Last revised
2
graded outcomes
0
references listed

Assembled by the app from other entries in this library. It adds no evidence of its own — follow the links to the entries it draws on.

2 at grade D — 2 graded rows

What is known

Each outcome with its grade (how strong the evidence is, A to D), the size of the effect where the entry records one, and how often studies agree.

  • AniracetamEvidence grade D

    Mostly preclinical

    Triviallow

  • DMAEEvidence grade D

    Mixed

    Triviallow

What is uncertain

Read off the same rows as above. Nothing here is added that the entry does not itself record.

  • Thin evidence: Aniracetam (grade D); DMAE (grade D).

The evidence in words

The evidence map

This is the ranked evidence for cognition / mood: every compound in the knowledge base with a graded effect, best-supported first. Grades reflect replication and effect size, not popularity or marketing.

Best-supported

No intervention here reaches grade A or B — an honest reflection of how thin the evidence for cognition / mood still is.

Weaker or unproven

Aniracetam (grade D) — Mostly preclinical · DMAE (grade D) — Mixed

Goes with

Entries that share this one's tags or conditions.

Sources

This entry lists no references of its own — it is assembled from the entries it links to, whose sources are on their pages.

Last revised . A grade is this entry's reading of the evidence, not medical advice.